COMPANY · NIPC 505282801

Bluepharma Indústria Farmacêutica,S.A.

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €360,950.12 across 51 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameBluepharma Indústria Farmacêutica,S.A.
NIPC505282801

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2020 to 2026. The table below gives the same values.2020: €5,792.2120202021: €1,084.0520212022: €35,978.2320222023: €56,540.2320232024: €135,164.1420242025: €40,373.4620252026: €86,017.802026€135,164.14
Contracted value by year
YearContractsContract value
20202€5,792.21
20212€1,084.05
20227€35,978.23
202316€56,540.23
202410€135,164.14
20256€40,373.46
20268€86,017.80
Contracted value by place of performance
NameContractsContract value
Almada22€201,677.91
Loures9€49,072.70
Braga3€28,570.50
Barreiro1€27,498.90
Lisboa5€15,638.23
Setúbal1€11,223.01
Évora2€9,444.90
Leiria2€9,300
Porto1€5,662.21
Oeiras1€1,929.90
Largest contracts
SubjectYearContract value
ABIRATERONA 500 MG COMP2024€42,749.99
ABIRATERONA 500 MG COMP2024€40,800
MEDICAMENTOS DIVERSOS AQ 2024/8992025€33,000
MEDICAMENTOS DIVERSOS - AQ 2021/122024€27,720
2026/0304 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 961/2024 - Medicamentos Diversos, 2025/1627 - Medicamentos do aparelho cardiovascular, 900/2024 - Medicamentos antirretrovíricos para o tratamento da infeção p2026€27,498.90

Who they competed with

In 38 contracts with a list of competitors, the company took part and was awarded 22 (58%).

Companies with the most procedures in common
CompanyProcedures in common
Bluepharma Genéricos - Comércio de Medicamentos S.A.19
Generis-Farmacêutica, S.A.18
Mylan, Lda.16
Hikma Farmaceutica, lda14
Sandoz, Lda.14
Overpharma-Produtos Médicos e Farmacêuticos, Lda12
Farmoz, S.A.11
Zentiva Portugal, Lda.11
Fresenius Kabi Pharma Portugal Lda.11
Labesfal-Laboratórios Almiro, S.A10
Teva pHarma10
Novartis Farma - Produtos Farmacêuticos, S.A.8
Merck Sharp & Dohme, Lda8
Accord Healthcare,Unipessoal Lda8
Roche Farmacêutica Química, Lda.6
LABORATÓRIOS NORMON, S.A.6
Abbvie, Lda6
BAYER PORTUGAL, SA.5
LABORATÓRIOS PFIZER LDA.5
Laboratório Medinfar, Produtos Farmacêuticos, SA5
Logista, Transportes, Transitários e Pharma, Unipessoal, Lda5
DLA FARMACEUTICA SA5
PharmaKern Portugal - Produtos Farmacêuticos Sociedade Unipessoal Lda5
PLS Pharma Produtos Farmacêuticos, Lda5
MEDAC SUCURSAL PORTUGAL5
GLAXOSMITHKLINE-PROD. FARMACÊUTICOS, LDA.4
Pharmis Biofarmacêutica, Lda.4
Lundbeck Portugal, Prod. Farm. Lda4
Alloga Logifarma, S.A.4
BIOJAM, SA4

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents42 companies and 60 links. The list below gives the same content as text.Novartis Farma… (NIPC 500063524)Novartis Farma…GLAXOSMITHKLIN… (NIPC 500139962)GLAXOSMITHKLIN…LABORATÓRIOS P… (NIPC 500162166)LABORATÓRIOS P…Labesfal-Labor… (NIPC 501169580)Labesfal-Labor…Farmoz, S.A. (NIPC 501505334)Farmoz, S.A.Mylan, Lda. (NIPC 502248793)Mylan, Lda.Hikma Farmaceu… (NIPC 502266791)Hikma Farmaceu…Zentiva Portug… (NIPC 503103551)Zentiva Portug…Logista, Trans… (NIPC 503538108)Logista, Trans…Alloga Logifar… (NIPC 503934640)Alloga Logifar…NIPC 505282801 (NIPC 505282801)NIPC 505282801+31 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.